Ambros Therapeutics

Leadership Tracker

Ambros Leadership Team to Run Combined Company After Werewolf Merger

As part of the all-stock merger between Werewolf Therapeutics and Ambros Therapeutics, Ambros CEO Joseph “Jay” Hagan will become CEO of the combined company, replacing Werewolf’s Daniel J. Hicklin. The full Ambros executive team,…

admin
August 21, 2026

Deals and Financing

Werewolf and Ambros Merge in All-Stock Deal to Fund Phase III Neridronate Trial

Werewolf Therapeutics and privately-held Ambros Therapeutics are combining in an all-stock, reverse-merger-style transaction, with Ambros valued pre-money at $500 million against Werewolf’s $47.5 million. A concurrent $150 million private placement, led by RA Capital…

admin
August 21, 2026

Ambros Leadership Team to Run Combined Company After Werewolf Merger

Werewolf and Ambros Merge in All-Stock Deal to Fund Phase III Neridronate Trial

Saturday Rounds